Drawing for PHEBRA

USPTO serial 88044450

PHEBRA

Reviewed by CopyMark Law Group

Reg. 5817862Status 702Registered
Filing date
Status date
Registration date
Jul 30, 2019
Examiner
EULIN, INGRID C
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with PHEBRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amber M. Underhill

Amber M. Underhill Warner Norcross + Judd LLP150 Ottawa Ave. NW, Suite 1500Grand Rapids, MI 49503United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of [ pain, cancer, infectious diseases, ] gastrointestinal diseases and conditions, [ skin conditions, respiratory conditions, ] neurological disorders, psychiatric disorders, genetic disorders, hormonal disorders, cardiovascular disorders, human ion imbalances; cardiovascular agents for medical purposes; medicines for human purposes, namely, medicines for the treatment of [ cancer, epilepsy and manic, ] depressive and psychotic states; medicinal preparations, namely, medicines for the treatment of [ cancer, epilepsy and manic, ] depressive and psychotic states; [ vitamin preparations; ] electrolyte solutions for medical use, namely, electrolyte replacement solutions [ ; vaccines; antidotes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; in-vivo diagnostic agents used to visualize and differentiate tissues in the body, or to monitor the functioning and patency of tissues and organs; injectable solutions for medical purposes, namely, sterile injectable dyes for in vivo human medical diagnostic procedures ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 26, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 26, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 16, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Jul 30, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 14, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 14, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 14, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 14, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 14, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 14, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 14, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 14, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 24, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 5, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 5, 2019ALIEASSIGNED TO LIE—
Mar 14, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 22, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 21, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 21, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 9, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 9, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 9, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2018DOCKASSIGNED TO EXAMINER—
Jul 24, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 23, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance